Cholecystokinin peptides in cerebrospinal fluid: a pilot study in hypothyroid patients
1999 (English)In: Human Psychopharmacology: Clinical and Experimental, ISSN 0885-6222, E-ISSN 1099-1077, Vol. 14, no 2, 113-117 p.Article in journal (Refereed) Published
The cholecystokinin tetrapeptide (CCK-4) and the sulphated octapeptide (CCK-8) were measured in cerebrospinal fluid obtained from nine hypothyroid patients before and during L-thyroxine treatment. Before treatment, CCK-4 and CCK-8S correlated negatively with S-TSH, whereas CCK-8S also showed a positive correlation with S-T3. During treatment, S-T4 correlated negatively with CCK-8S. CSF collection time was significantly shorter during treatment than prior to treatment for the first (0–6 ml) CSF fraction. On taking CSF collection time into account, the levels of both CCK-4 and CCK-8S in the first CSF fraction were significantly increased during medication. Our results are consistent with an impact of the hypothyroid disorder and L-thyroxine treatment on the disposition of CCK compounds in CSF. This might be due to an altered CSF circulation, but other mechanisms (e.g. metabolism or elimination) cannot be ruled out.
Place, publisher, year, edition, pages
1999. Vol. 14, no 2, 113-117 p.
hypothyroidism, cholecystokinin, cerebrospinal fluid, CSF collection time, atmospheric pressure
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:liu:diva-27798DOI: 10.1002/(SICI)1099-1077(199903)14:2<113::AID-HUP76>3.0.CO;2-ALocal ID: 12545OAI: oai:DiVA.org:liu-27798DiVA: diva2:248350